Clinical Trials · NCT00882050
Intravenous Exenatide (Byetta) During Surgery
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Thomas Jefferson University
- Enrollment
- 104
- Start date
- Mar 2009
- Locations
- 1 site, United States
- Primary endpoint
- The Primary Objective is to Determine the Ability of Intravenous Exenatide to: Maintain Intraoperative Euglycemia in Subjects With Initial Blood Glucose < 126 mg/dL in Surgical Subjects as Compared to Placebo,